Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Current Neuropharmacology|March 22, 2023
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)Sebastiano Arena, Clara Grazia Chisari, Simona Toscano, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 16, 2025
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patientsClara G Chisari, Salvatore Lo Fermo, Salvatore Iacono, et al.Journal of Neurology|December 24, 2025
Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study)Clara Grazia Chisari, Salvatore Lo Fermo, Alessia Di Sapio, et al.JAMA Neurology|July 1, 2014
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study)Marinella Clerico, Irene Schiavetti, Stefania F De Mercanti, et al.Plos One|March 28, 2015
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patientsFrancesco Patti, Manuela De Stefano, Luigi Lavorgna, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.Multiple Sclerosis and Related Disorders|October 15, 2019
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disordersGiovanni Novi, Francesca Bovis, Marco Capobianco, et al.Journal of Neurology|February 22, 2021
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy studySebastiano Bucello, Pietro Annovazzi, Paolo Ragonese, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 12, 2024
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancyDoriana Landi, Silvia Bartolomeo, Francesca Bovis, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2019
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experienceChiara Zecca, Francesca Bovis, Giovanni Novi, et al.Pageof 4